Genpact SVP sells 14,972 shares near $34.10

Genpact LTD (G) reported that Senior Vice President Sameer Dewan sold a total of 14,972 Common Shares on 2026-08-14 in open market or private transactions.

Rhea-AI Filing Summary

Genpact LTD (G) reported that Senior Vice President Sameer Dewan sold a total of 14,972 Common Shares on 2026-08-14 in open market or private transactions. One block of 1,654 shares was sold at $34.10 per share, and another block of 13,318 shares was sold at a weighted average price of $34.10, with sales prices ranging from $34.10 to $34.11. Post-transaction share holdings were not reported in this filing.

Insider Trade Summary

Net Seller: 14,972 shares

Net Sell 2 txns

Insider Dewan Sameer

Role Senior Vice President

Sold 14,972 shs ($511K)

Type	Security	Shares	Price	Value
Sale	Common Shares	1,654	$34.10	$56K
Sale	Common Shares F1	13,318	$34.10	$454K

Holdings After Transaction: Common Shares — 42,693 shares (Direct)

Footnotes (1)

1. F1. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $34.10 to $34.11. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Key Figures

Shares sold (total): 14,972 shares First sale size: 1,654 shares Second sale size: 13,318 shares +3 more

6 metrics

Shares sold (total) 14,972 shares Total Common Shares sold by Sameer Dewan on 2026-08-14

First sale size 1,654 shares Common Shares sold in one transaction on 2026-08-14

Second sale size 13,318 shares Common Shares sold in weighted-average priced transaction on 2026-08-14

Sale price (fixed block) $34.10 per share Per-share sale price for 1,654-share transaction

Weighted average sale price $34.10 per share Weighted average for 13,318-share sale; actual prices ranged $34.10–$34.11

Price range (second sale) $34.10 to $34.11 per share Range of actual prices within the weighted-average transaction

Key Terms

weighted average price, open market or private transaction, Common Shares

3 terms

weighted average price financial

"The price in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

Common Shares financial

"security_title: Common Shares"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Genpact (G) report for Sameer Dewan on August 14, 2026?

Genpact (G) reported that Senior Vice President Sameer Dewan sold 14,972 Common Shares on 2026-08-14 in open market or private transactions at prices around $34.10 per share.

How many Genpact (G) shares did Sameer Dewan sell in each transaction?

Sameer Dewan sold 1,654 Common Shares in one transaction and 13,318 Common Shares in a second transaction, for a total of 14,972 shares disposed of on 2026-08-14.

At what prices were Sameer Dewan’s Genpact (G) shares sold?

One block was sold at $34.10 per share. The second block used a weighted average price of $34.10, with individual sale prices ranging from $34.10 to $34.11 per share.

Were Sameer Dewan’s Genpact (G) share sales made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan, and no footnote states that the August 14, 2026 sales were made pursuant to a Rule 10b5-1 plan.

Does the Form 4 disclose Sameer Dewan’s Genpact (G) holdings after these sales?

The Form 4 does not report a specific number of Genpact (G) Common Shares owned by Sameer Dewan following the 14,972-share sale on 2026-08-14; the relevant fields are left blank.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:02 PM Accepted by SEC EDGAR 08/18/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dewan Sameer

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NEW YORK 10175

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/14/2026		S		1,654	D	$34.1	56,011	D
Common Shares	08/14/2026		S		13,318	D	$34.1(1)	42,693	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $34.10 to $34.11. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Sameer Dewan	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)